tetano
Editor, Senior Moderator
Can Commun Dis Rep. 2020 Jan 2;46(5):25-28. doi: 10.14745/ccdr.v46i01a05. eCollection 2020 Jan 2. [h=1]National Influenza Mid-Season Report, 2019-2020.[/h]
Sevenhuysen C[SUP]1[/SUP], Lee L[SUP]1[/SUP], Nwosu A[SUP]1[/SUP], Smith T[SUP]1[/SUP], Whitmore L[SUP]1[/SUP], Bastien N[SUP]2[/SUP], Desroches M[SUP]1[/SUP], Bancej C[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Canada's national influenza season started in week 47 between November 17 to 23, 2019. Of the 3,762 laboratory-confirmed influenza detections reported from August 25 to December 14, 2019, 61% were influenza A, and of those subtyped, 68% were A(H3N2). Influenza B detections are above average for this time of year. Indicators of influenza activity are within the expected range for this time of year. The majority of hospitalizations reported by provinces and territories have been associated with influenza A(H3N2) (76%), and the greatest proportion have been among adults 65 years and older (40%). Among sentinel pediatric influenza hospitalizations, 55% were associated with influenza B and the majority have been under five years of age (63%). Antigenic and genetic characterization results to date suggest that the majority of circulating A(H3N2) and B viruses are not similar to the virus components recommended for use in the 2019-2020 seasonal influenza vaccines and that the majority of circulating A(H1N1) viruses are similar to the vaccine reference strains.
[h=4]KEYWORDS:[/h] H1N1; H3N2; influenza; outbreaks; surveillance
PMID: 31930211 PMCID: PMC6941920 DOI: 10.14745/ccdr.v46i01a05
Free full text
Sevenhuysen C[SUP]1[/SUP], Lee L[SUP]1[/SUP], Nwosu A[SUP]1[/SUP], Smith T[SUP]1[/SUP], Whitmore L[SUP]1[/SUP], Bastien N[SUP]2[/SUP], Desroches M[SUP]1[/SUP], Bancej C[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Canada's national influenza season started in week 47 between November 17 to 23, 2019. Of the 3,762 laboratory-confirmed influenza detections reported from August 25 to December 14, 2019, 61% were influenza A, and of those subtyped, 68% were A(H3N2). Influenza B detections are above average for this time of year. Indicators of influenza activity are within the expected range for this time of year. The majority of hospitalizations reported by provinces and territories have been associated with influenza A(H3N2) (76%), and the greatest proportion have been among adults 65 years and older (40%). Among sentinel pediatric influenza hospitalizations, 55% were associated with influenza B and the majority have been under five years of age (63%). Antigenic and genetic characterization results to date suggest that the majority of circulating A(H3N2) and B viruses are not similar to the virus components recommended for use in the 2019-2020 seasonal influenza vaccines and that the majority of circulating A(H1N1) viruses are similar to the vaccine reference strains.
[h=4]KEYWORDS:[/h] H1N1; H3N2; influenza; outbreaks; surveillance
PMID: 31930211 PMCID: PMC6941920 DOI: 10.14745/ccdr.v46i01a05
Free full text